-
1
-
-
0037135111
-
The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
-
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
-
(2002)
Science
, vol.297
, pp. 353-356
-
-
Hardy, J.1
Selkoe, D.J.2
-
2
-
-
84859632987
-
A- imaging: Feasible, pertinent, and vital to progress in Alzheimer's disease
-
Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, Morris JC, Nordberg A, Petersen RC, Reiman EM, Selkoe DJ, Sperling RA,Van Laere K,WeinerMW, DrzezgaA (2012) A- imaging: Feasible, pertinent, and vital to progress in Alzheimer's disease. Eur J Nucl Med Mol Imaging 39, 209-219.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, pp. 209-219
-
-
Villemagne, V.L.1
Klunk, W.E.2
Mathis, C.A.3
Rowe, C.C.4
Brooks, D.J.5
Hyman, B.T.6
Ikonomovic, M.D.7
Ishii, K.8
Jack, C.R.9
Jagust, W.J.10
Johnson, K.A.11
Koeppe, R.A.12
Lowe, V.J.13
Masters, C.L.14
Montine, T.J.15
Morris, J.C.16
Nordberg, A.17
Petersen, R.C.18
Reiman, E.M.19
Selkoe, D.J.20
Sperling, R.A.21
Van Laere, K.22
Weiner, M.W.23
Drzezga, A.24
more..
-
3
-
-
80054909832
-
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease
-
Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, Joshi AD, Clark CM, Mintun MA, Pontecorvo MJ, Doraiswamy PM, Johnson KA, SkovronskyDM, Reiman EM (2011) Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol 68, 1404-1411.
-
(2011)
Arch Neurol
, vol.68
, pp. 1404-1411
-
-
Fleisher, A.S.1
Chen, K.2
Liu, X.3
Roontiva, A.4
Thiyyagura, P.5
Ayutyanont, N.6
Joshi, A.D.7
Clark, C.M.8
Mintun, M.A.9
Pontecorvo, M.J.10
Doraiswamy, P.M.11
Johnson, K.A.12
Skovronsky, D.M.13
Reiman, E.M.14
-
4
-
-
34248560960
-
Amyloid- in Alzheimer disease: The null versus the alternate hypotheses
-
Lee H, Zhu X, Castellani RJ, Nunomura A, Perry G, Smith MA (2007) Amyloid- in Alzheimer disease: The null versus the alternate hypotheses. J Pharm Exp Therap 321, 823-829.
-
(2007)
J Pharm Exp Therap
, vol.321
, pp. 823-829
-
-
Lee, H.1
Zhu, X.2
Castellani, R.J.3
Nunomura, A.4
Perry, G.5
Smith, M.A.6
-
5
-
-
84862504236
-
The toxicity of amyloid - oligomers
-
Zhao LN, Long HW, Mu Y, Chew LY (2012) The toxicity of amyloid - oligomers. Int J Mol Sci 13, 7303-7327.
-
(2012)
Int J Mol Sci
, vol.13
, pp. 7303-7327
-
-
Zhao, L.N.1
Long, H.W.2
Mu, Y.3
Chew, L.Y.4
-
6
-
-
79955822574
-
The role of the immune system in Alzheimer's disease
-
Cohen RM (2009) The role of the immune system in Alzheimer's disease. J Lifelong Learning Psych 7, 28-35.
-
(2009)
J Lifelong Learning Psych
, vol.7
, pp. 28-35
-
-
Cohen, R.M.1
-
7
-
-
84859646610
-
Amyloid- imaging with PET in Alzheimer's disease: Is it feasible with current radiotracers and technologies?
-
Moghbel MC, Saboury B, Basu S, Metzler SD, Torigian DA, Langstrom B, Alavi A (2012) Amyloid- imaging with PET in Alzheimer's disease: Is it feasible with current radiotracers and technologies?. Eur J Nucl Med Mol Imaging 39, 202-208.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, pp. 202-208
-
-
Moghbel, M.C.1
Saboury, B.2
Basu, S.3
Metzler, S.D.4
Torigian, D.A.5
Langstrom, B.6
Alavi, A.7
-
8
-
-
53749108464
-
Amyloid- vaccination for Alzheimer's dementia
-
Holtzman JL (2008) Amyloid- vaccination for Alzheimer's dementia. Lancet 372, 1381.
-
(2008)
Lancet
, vol.372
, pp. 1381
-
-
Holtzman, J.L.1
-
9
-
-
84857558439
-
Immunotherapy for Alzheimer's disease: From anti-amyloid to tau-based immunization strategies
-
Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A (2012) Immunotherapy for Alzheimer's disease: From anti-amyloid to tau-based immunization strategies. Immunotherapy 4, 213-238.
-
(2012)
Immunotherapy
, vol.4
, pp. 213-238
-
-
Panza, F.1
Frisardi, V.2
Solfrizzi, V.3
Imbimbo, B.P.4
Logroscino, G.5
Santamato, A.6
Greco, A.7
Seripa, D.8
Pilotto, A.9
-
10
-
-
84881460680
-
Bapineuzumab Phase 3: Target engagement, but no benefit
-
Fagan T (2012) Bapineuzumab Phase 3: Target engagement, but no benefit. Alzheimer Research Forum, http://www. alzforum.org/new/detail.asp?id=3268
-
(2012)
Alzheimer Research Forum
-
-
Fagan, T.1
-
11
-
-
84881432242
-
Drug company halts development of -secretase inhibitor avagacestat
-
Dickey Zakaib G (2012) Drug company halts development of -secretase inhibitor avagacestat. Alzheimer Research Forum, http://www.alzforum.org/new/ detail.asp?id=3344
-
(2012)
Alzheimer Research Forum
-
-
Dickey Zakaib, G.1
-
12
-
-
84868516038
-
Safety and tolerability of the -secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease
-
Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, RichterRW, Soininen H, Thein S, Shiovitz T, Pilcher G, Colby S, Rollin L, Dockens R, Pachai C, Portelius E, Andreasson U, Blennow K, Soares H, Albright C, Feldman HH, Berman RM (2012) Safety and tolerability of the -secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease. Arch Neurol 69, 1430-1440.
-
(2012)
Arch Neurol
, vol.69
, pp. 1430-1440
-
-
Coric, V.1
Van Dyck, C.H.2
Salloway, S.3
Andreasen, N.4
Brody, M.5
Richter, R.W.6
Soininen, H.7
Thein, S.8
Shiovitz, T.9
Pilcher, G.10
Colby, S.11
Rollin, L.12
Dockens, R.13
Pachai, C.14
Portelius, E.15
Andreasson, U.16
Blennow, K.17
Soares, H.18
Albright, C.19
Feldman, H.H.20
Berman, R.M.21
more..
-
13
-
-
84860215480
-
Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature
-
Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kövari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature. J Neuropathol Exp Neurol 71, 362-381.
-
(2012)
J Neuropathol Exp Neurol
, vol.71
, pp. 362-381
-
-
Nelson, P.T.1
Alafuzoff, I.2
Bigio, E.H.3
Bouras, C.4
Braak, H.5
Cairns, N.J.6
Castellani, R.J.7
Crain, B.J.8
Davies, P.9
Del Tredici, K.10
Duyckaerts, C.11
Frosch, M.P.12
Haroutunian, V.13
Hof, P.R.14
Hulette, C.M.15
Hyman, B.T.16
Iwatsubo, T.17
Jellinger, K.A.18
Jicha, G.A.19
Kövari, E.20
Kukull, W.A.21
Leverenz, J.B.22
Love, S.23
Mackenzie, I.R.24
Mann, D.M.25
Masliah, E.26
McKee, A.C.27
Montine, T.J.28
Morris, J.C.29
Schneider, J.A.30
Sonnen, J.A.31
Thal, D.R.32
Trojanowski, J.Q.33
Troncoso, J.C.34
Wisniewski, T.35
Woltjer, R.L.36
Beach, T.G.37
more..
-
14
-
-
84857030932
-
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: A practical approach
-
Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: A practical approach. Acta Neuropathol 123, 1-11.
-
(2012)
Acta Neuropathol
, vol.123
, pp. 1-11
-
-
Montine, T.J.1
Phelps, C.H.2
Beach, T.G.3
Bigio, E.H.4
Cairns, N.J.5
Dickson, D.W.6
Duyckaerts, C.7
Frosch, M.P.8
Masliah, E.9
Mirra, S.S.10
Nelson, P.T.11
Schneider, J.A.12
Thal, D.R.13
Trojanowski, J.Q.14
Vinters, H.V.15
Hyman, B.T.16
-
15
-
-
84856002055
-
Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
-
Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ (2012) Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 8, 1-13.
-
(2012)
Alzheimers Dement
, vol.8
, pp. 1-13
-
-
Hyman, B.T.1
Phelps, C.H.2
Beach, T.G.3
Bigio, E.H.4
Cairns, N.J.5
Carrillo, M.C.6
Dickson, D.W.7
Duyckaerts, C.8
Frosch, M.P.9
Masliah, E.10
Mirra, S.S.11
Nelson, P.T.12
Schneider, J.A.13
Thal, D.R.14
Thies, B.15
Trojanowski, J.Q.16
Vinters, H.V.17
Montine, T.J.18
-
16
-
-
0037172826
-
Phases of A beta-deposition in the human brain and its relevance for the development of AD
-
Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800.
-
(2002)
Neurology
, vol.58
, pp. 1791-1800
-
-
Thal, D.R.1
Rüb, U.2
Orantes, M.3
Braak, H.4
-
17
-
-
0033624303
-
Sequence of Abeta-protein deposition in the human medial temporal lobe
-
Thal DR, Rüb U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, Braak E, Braak H (2000) Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59, 733-748.
-
(2000)
J Neuropathol Exp Neurol
, vol.59
, pp. 733-748
-
-
Thal, D.R.1
Rüb, U.2
Schultz, C.3
Sassin, I.4
Ghebremedhin, E.5
Del Tredici, K.6
Braak, E.7
Braak, H.8
-
18
-
-
0025863618
-
Neuropathological stageing of Alzheimer-related changes
-
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
-
(1991)
Acta Neuropathol
, vol.82
, pp. 239-259
-
-
Braak, H.1
Braak, E.2
-
19
-
-
0025908356
-
The consortium to establish a registry for alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
-
Mirra SS, Heyman A,McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
-
(1991)
Neurology
, vol.41
, pp. 479-486
-
-
Mirra, S.S.1
Heyman, A.2
McKeel, D.3
Sumi, S.M.4
Crain, B.J.5
Brownlee, L.M.6
Vogel, F.S.7
Hughes, J.P.8
Van Belle, G.9
Berg, L.10
-
20
-
-
0038792263
-
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents
-
Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, KlunkWE(2003) Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46, 2740-2754.
-
(2003)
J Med Chem
, vol.46
, pp. 2740-2754
-
-
Mathis, C.A.1
Wang, Y.2
Holt, D.P.3
Huang, G.F.4
Debnath, M.L.5
Klunk, W.E.6
-
21
-
-
67650430010
-
Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta
-
Waibel M, De Angelis M, Stossi F, Kieser KJ, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA (2009) Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta. Eur J Med Chem 44, 3412-3424.
-
(2009)
Eur J Med Chem
, vol.44
, pp. 3412-3424
-
-
Waibel, M.1
De Angelis, M.2
Stossi, F.3
Kieser, K.J.4
Carlson, K.E.5
Katzenellenbogen, B.S.6
Katzenellenbogen, J.A.7
-
22
-
-
84881463316
-
Radiosyn thesis, biodistribution and metabolic fate of three PET agents for amyloid-in rats: [18F]flutemetamol, florbetapir F18 (18F-AV-45) and florbetaben (BAY 94-9172). PW012)
-
Jackson A, Smith GE, Brown SL, Morisson-Iveson V, Chau W, Durrant CL, Wilson IA (2011) Radiosynthesis, biodistribution and metabolic fate of three PET agents for amyloid- in rats: [18F]flutemetamol, florbetapir F18 (18F-AV-45) and florbetaben (BAY 94-9172) (PW012). Eur J Nucl Med Mol Imaging 38(Suppl 2), S231-S232.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, Issue.SUPPL. 2
-
-
Jackson, A.1
Smith, G.E.2
Brown, S.L.3
Morisson-Iveson, V.4
Chau, W.5
Durrant, C.L.6
Wilson, I.A.7
-
23
-
-
70350716476
-
Preclinical properties of 18F-AV-45: A PET agent for Abeta plaques in the brain
-
Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, Benedum TE, Kilbourn MR, Skovronsky D, Kung HF (2009) Preclinical properties of 18F-AV-45: A PET agent for Abeta plaques in the brain. J Nucl Med 50, 1887-1894.
-
(2009)
J Nucl Med
, vol.50
, pp. 1887-1894
-
-
Choi, S.R.1
Golding, G.2
Zhuang, Z.3
Zhang, W.4
Lim, N.5
Hefti, F.6
Benedum, T.E.7
Kilbourn, M.R.8
Skovronsky, D.9
Kung, H.F.10
-
24
-
-
84859443015
-
Study the pharmacokinetics of AV-45 in rat plasma and metabolism in liver microsomes by ultra-performance liquid chromatography with mass spectrometry
-
Yin W, Zhou X, Qiao J, Zhu L (2012) Study the pharmacokinetics of AV-45 in rat plasma and metabolism in liver microsomes by ultra-performance liquid chromatography with mass spectrometry. Biomed Chromatogr 26, 666-671.
-
(2012)
Biomed Chromatogr
, vol.26
, pp. 666-671
-
-
Yin, W.1
Zhou, X.2
Qiao, J.3
Zhu, L.4
-
25
-
-
0029743481
-
Distribution volume ratios without blood sampling from graphical analysis of PET data
-
Logan J, Fowler JS, Volkow ND,Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16, 834-840.
-
(1996)
J Cereb Blood Flow Metab
, vol.16
, pp. 834-840
-
-
Logan, J.1
Fowler, J.S.2
Volkow, N.D.3
Wang, G.J.4
Ding, Y.S.5
Alexoff, D.L.6
-
26
-
-
79955855908
-
Florbetapir-PET imaging and postmortem -amyloid pathology
-
Carome M, Wolfe S (2011) Florbetapir-PET imaging and postmortem -amyloid pathology. JAMA 305, 1857-1858.
-
(2011)
JAMA
, vol.305
, pp. 1857-1858
-
-
Carome, M.1
Wolfe, S.2
-
28
-
-
0035902875
-
Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain
-
Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Mathis CA (2001) Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69, 1471-1484.
-
(2001)
Life Sci
, vol.69
, pp. 1471-1484
-
-
Klunk, W.E.1
Wang, Y.2
Huang, G.F.3
Debnath, M.L.4
Holt, D.P.5
Mathis, C.A.6
-
29
-
-
10744232413
-
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound- B
-
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Auśen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, L̊angström B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound- B. Ann Neurol 55, 306-319.
-
(2004)
Ann Neurol
, vol.55
, pp. 306-319
-
-
Klunk, W.E.1
Engler, H.2
Nordberg, A.3
Wang, Y.4
Blomqvist, G.5
Holt, D.P.6
Bergström, M.7
Savitcheva, I.8
Huang, G.F.9
Estrada, S.10
Auśen, B.11
Debnath, M.L.12
Barletta, J.13
Price, J.C.14
Sandell, J.15
Lopresti, B.J.16
Wall, A.17
Koivisto, P.18
Antoni, G.19
Mathis, C.A.20
L̊angström, B.21
more..
-
30
-
-
77952320068
-
Molecular mechanism of Thioflavin-T binding to amyloid fibrils
-
Biancalana M, Koide S (2010) Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 1804, 1405-1412.
-
(2010)
Biochim Biophys Acta
, vol.1804
, pp. 1405-1412
-
-
Biancalana, M.1
Koide, S.2
-
31
-
-
0345415139
-
2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): Novel diagnostic and therapeutic tools in Alzheimer's disease
-
Agdeppa ED, Kepe V, Liu J, Small GW, Huang SC, Petric A, Satyamurthy N, Barrio JR (2003) 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): Novel diagnostic and therapeutic tools in Alzheimer's disease. Mol Imaging Biol 5, 404-417.
-
(2003)
Mol Imaging Biol
, vol.5
, pp. 404-417
-
-
Agdeppa, E.D.1
Kepe, V.2
Liu, J.3
Small, G.W.4
Huang, S.C.5
Petric, A.6
Satyamurthy, N.7
Barrio, J.R.8
-
32
-
-
33846032313
-
Radioligand development for PET imaging of -amyloid (A-) - current status
-
Cai L, Innis R, Pike VW(2007) Radioligand development for PET imaging of -amyloid (A-) - current status. Curr Med Chem 14, 19-52.
-
(2007)
Curr Med Chem
, vol.14
, pp. 19-52
-
-
Cai, L.1
Innis, R.2
Pike, V.W.3
-
33
-
-
79959791904
-
Towards a pharmacophore for amyloid
-
Landau M, Sawaya MR, Faull KF, Laganowsky A, Jiang L, Sievers SA, Liu J, Barrio JR, Eisenberg D (2011) Towards a pharmacophore for amyloid. PLoS Biol 2011, e1001080-.
-
(2011)
PLoS Biol
, vol.2011
-
-
Landau, M.1
Sawaya, M.R.2
Faull, K.F.3
Laganowsky, A.4
Jiang, L.5
Sievers, S.A.6
Liu, J.7
Barrio, J.R.8
Eisenberg, D.9
-
34
-
-
0035968202
-
Thioflavin T is a fluorescent probe of the acetylcholinesterase peripheral site that reveals conformational interactions between the peripheral and acylation sites
-
De Ferrari GV, Mallender WC, Inestrosa NC, Rosenberry TL (2001) Thioflavin T is a fluorescent probe of the acetylcholinesterase peripheral site that reveals conformational interactions between the peripheral and acylation sites. J Biol Chem 276, 23282-23287.
-
(2001)
J Biol Chem
, vol.276
, pp. 23282-23287
-
-
De Ferrari, G.V.1
Mallender, W.C.2
Inestrosa, N.C.3
Rosenberry, T.L.4
-
35
-
-
0345874563
-
Emission of thioflavin T and its control in the presence of DNA
-
Ilanchelian M, RamarajR(2004) Emission of thioflavin T and its control in the presence of DNA. J Photochem Photobiol A Chem 162, 129-137.
-
(2004)
J Photochem Photobiol A Chem
, vol.162
, pp. 129-137
-
-
Ilanchelian, M.1
Ramaraj, R.2
-
36
-
-
59249089318
-
Characterization of PiB binding to white matter in Alzheimer disease and other dementias
-
Fodero-Tavoletti MT, Rowe CC, McLean CA, Leone L, Li QX, Masters CL, Cappai R, Villemagne VL (2009) Characterization of PiB binding to white matter in Alzheimer disease and other dementias. J Nucl Med 50, 198-204.
-
(2009)
J Nucl Med
, vol.50
, pp. 198-204
-
-
Fodero-Tavoletti, M.T.1
Rowe, C.C.2
McLean, C.A.3
Leone, L.4
Li, Q.X.5
Masters, C.L.6
Cappai, R.7
Villemagne, V.L.8
-
37
-
-
79954748692
-
Cerebral amyloid- PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls:Amulticentre phase 2 diagnostic study
-
Florbetaben Study Group.
-
Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O, Florbetaben Study Group (2011) Cerebral amyloid- PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls:Amulticentre phase 2 diagnostic study. Lancet Neurol 10, 424-435.
-
(2011)
Lancet Neurol
, vol.10
, pp. 424-435
-
-
Barthel, H.1
Gertz, H.J.2
Dresel, S.3
Peters, O.4
Bartenstein, P.5
Buerger, K.6
Hiemeyer, F.7
Wittemer-Rump, S.M.8
Seibyl, J.9
Reininger, C.10
Sabri, O.11
-
38
-
-
79958033200
-
The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease
-
Thomas BA, Erlandsson K, Modat M, Thurfjell L, Vandenberghe R, Ourselin S, Hutton BF (2011) The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease. Eur J Nucl Med Mol Imaging 38, 1104-1119.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, pp. 1104-1119
-
-
Thomas, B.A.1
Erlandsson, K.2
Modat, M.3
Thurfjell, L.4
Vandenberghe, R.5
Ourselin, S.6
Hutton, B.F.7
-
39
-
-
41849090440
-
Pittfalls of MRI measurement of white matter perfusion based on arterial spin labeling
-
Van Gelderen P, de Zwart JA, Duyn JH (2008) Pittfalls of MRI measurement of white matter perfusion based on arterial spin labeling. Magn Reson Med 59, 788-795.
-
(2008)
Magn Reson Med
, vol.59
, pp. 788-795
-
-
Van Gelderen, P.1
De Zwart, J.A.2
Duyn, J.H.3
-
40
-
-
84859628004
-
Comparison of relative cerebral blood flow maps using pseudo-continuous arterial spin labeling and single photon emission computed tomography
-
Liu P, Uh J, Devous MD, Adinoff B, LuH(2012) Comparison of relative cerebral blood flow maps using pseudo-continuous arterial spin labeling and single photon emission computed tomography. NMR Biomed 25, 779-786.
-
(2012)
NMR Biomed
, vol.25
, pp. 779-786
-
-
Liu, P.1
Uh, J.2
Devous, M.D.3
Adinoff, B.4
Lu, H.5
-
41
-
-
0031757230
-
Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes
-
Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, Hatano K, Sasaki T (1998) Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology 40, 131-137.
-
(1998)
Neuroradiology
, vol.40
, pp. 131-137
-
-
Tohgi, H.1
Yonezawa, H.2
Takahashi, S.3
Sato, N.4
Kato, E.5
Kudo, M.6
Hatano, K.7
Sasaki, T.8
-
42
-
-
84866744392
-
White matter hyperintensities predict amyloid increase in Alzheimer's disease
-
Grimmer T, Faust M, Auer F, Alexopoulos P, Forstl H, Henriksen G, Perneczky R, Sorg C, Yousefi BH, Drzezga A, Kurz A (2012) White matter hyperintensities predict amyloid increase in Alzheimer's disease. Neurobiol Aging 33, 2766-2773.
-
(2012)
Neurobiol Aging
, vol.33
, pp. 2766-2773
-
-
Grimmer, T.1
Faust, M.2
Auer, F.3
Alexopoulos, P.4
Forstl, H.5
Henriksen, G.6
Perneczky, R.7
Sorg, C.8
Yousefi, B.H.9
Drzezga, A.10
Kurz, A.11
-
43
-
-
80051688987
-
Amyloid imaging with 18)F-florbetaben in Alzheimer disease and other dementias
-
Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, O'Keefe G, Ackerman U, Tochon-Danguy H, Chan JG, Reininger CB, Fels L, Putz B, Rohde B, Masters CL, Rowe CC (2011) Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med 52, 1210-1217.
-
(2011)
J Nucl Med
, vol.52
, pp. 1210-1217
-
-
Villemagne, V.L.1
Ong, K.2
Mulligan, R.S.3
Holl, G.4
Pejoska, S.5
Jones, G.6
O'Keefe, G.7
Ackerman, U.8
Tochon-Danguy, H.9
Chan, J.G.10
Reininger, C.B.11
Fels, L.12
Putz, B.13
Rohde, B.14
Masters, C.L.15
Rowe, C.C.16
-
44
-
-
77954033257
-
Amyloid imaging results from the Australian imaging Biomarkers and Lifestyle (AIBL) study of aging
-
Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL (2010) Amyloid imaging results from the Australian imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31, 1275-1283.
-
(2010)
Neurobiol Aging
, vol.31
, pp. 1275-1283
-
-
Rowe, C.C.1
Ellis, K.A.2
Rimajova, M.3
Bourgeat, P.4
Pike, K.E.5
Jones, G.6
Fripp, J.7
Tochon-Danguy, H.8
Morandeau, L.9
O'Keefe, G.10
Price, R.11
Raniga, P.12
Robins, P.13
Acosta, O.14
Lenzo, N.15
Szoeke, C.16
Salvado, O.17
Head, R.18
Martins, R.19
Masters, C.L.20
Ames, D.21
Villemagne, V.L.22
more..
-
45
-
-
77956384880
-
18Fflutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
-
Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ (2010) 18Fflutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Ann Neurol 68, 319-329.
-
(2010)
Ann Neurol
, vol.68
, pp. 319-329
-
-
Vandenberghe, R.1
Van Laere, K.2
Ivanoiu, A.3
Salmon, E.4
Bastin, C.5
Triau, E.6
Hasselbalch, S.7
Law, I.8
Andersen, A.9
Korner, A.10
Minthon, L.11
Garraux, G.12
Nelissen, N.13
Bormans, G.14
Buckley, C.15
Owenius, R.16
Thurfjell, L.17
Farrar, G.18
Brooks, D.J.19
-
46
-
-
77953937194
-
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir F 18)
-
Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasíc JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, Pontecorvo MJ (2010) In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir F 18). J Nucl Med 51, 913-920.
-
(2010)
J Nucl Med
, vol.51
, pp. 913-920
-
-
Wong, D.F.1
Rosenberg, P.B.2
Zhou, Y.3
Kumar, A.4
Raymont, V.5
Ravert, H.T.6
Dannals, R.F.7
Nandi, A.8
Brasíc, J.R.9
Ye, W.10
Hilton, J.11
Lyketsos, C.12
Kung, H.F.13
Joshi, A.D.14
Skovronsky, D.M.15
Pontecorvo, M.J.16
-
47
-
-
84862686384
-
Comparison of 11C-PiB and 18F-florbetaben for A- imaging in ageing and Alzheimer's disease
-
Villemagne VL, Mulligan RS, Pejoska S, Ong K, Jones G, O'Keefe G, Chan JG, Young K, Tochon-Danguy H, Masters CL, Rowe CC (2012) Comparison of 11C-PiB and 18F-florbetaben for A- imaging in ageing and Alzheimer's disease. Eur J Nucl Med Mol Imaging 39, 983-989.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, pp. 983-989
-
-
Villemagne, V.L.1
Mulligan, R.S.2
Pejoska, S.3
Ong, K.4
Jones, G.5
O'Keefe, G.6
Chan, J.G.7
Young, K.8
Tochon-Danguy, H.9
Masters, C.L.10
Rowe, C.C.11
-
48
-
-
79955379054
-
Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C] 2-(4'-methylaminophenyl)-6- hydroxybenzothiazole
-
Stankoff B, Freeman L, Aigrot MS, Chardain A, Dolé F, Williams A, Galanaud D, Armand L, Lehericy S, Lubetzki C, Zalc B, Bottlaender M (2011) Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4'-methylaminophenyl)-6- hydroxybenzothiazole. Ann Neurol 69, 673-680.
-
(2011)
Ann Neurol
, vol.69
, pp. 673-680
-
-
Stankoff, B.1
Freeman, L.2
Aigrot, M.S.3
Chardain, A.4
Dolé, F.5
Williams, A.6
Galanaud, D.7
Armand, L.8
Lehericy, S.9
Lubetzki, C.10
Zalc, B.11
Bottlaender, M.12
-
49
-
-
56249096579
-
Molecular probes for imaging myelinated white matter in CNS
-
Wu C, Wei J, Tian D, Feng Y, Miller RH, Wang Y (2008) Molecular probes for imaging myelinated white matter in CNS. J Med Chem 51, 6682-6688.
-
(2008)
J Med Chem
, vol.51
, pp. 6682-6688
-
-
Wu, C.1
Wei, J.2
Tian, D.3
Feng, Y.4
Miller, R.H.5
Wang, Y.6
-
50
-
-
78649449000
-
A novel PET marker for in vivo quantification of myelination
-
Wu C, Wang C, Popescu DC, Zhu W, Somoza EA, Zhu J, CondieAG, Flask CA, Miller RH, MacklinW,WangY(2010) A novel PET marker for in vivo quantification of myelination. Bioorg Med Chem 18, 8592-8599.
-
(2010)
Bioorg Med Chem
, vol.18
, pp. 8592-8599
-
-
Wu, C.1
Wang, C.2
Popescu, D.C.3
Zhu, W.4
Somoza, E.A.5
Zhu, J.6
Condie, A.G.7
Flask, C.A.8
Miller, R.H.9
Macklin, W.10
Wang, Y.11
-
51
-
-
81355164296
-
Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology
-
Wolk DA, Grachev ID, Buckley C, Kazi H, Grady MS, Trojanowski JQ, Hamilton RH, Sherwin P, McLain R, Arnold SE (2011) Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Arch Neurol 68, 1398-1403.
-
(2011)
Arch Neurol
, vol.68
, pp. 1398-1403
-
-
Wolk, D.A.1
Grachev, I.D.2
Buckley, C.3
Kazi, H.4
Grady, M.S.5
Trojanowski, J.Q.6
Hamilton, R.H.7
Sherwin, P.8
McLain, R.9
Arnold, S.E.10
-
52
-
-
78751546481
-
Use of florbetapir-PET for imaging -amyloid pathology
-
for the AV45-A07 Study Group
-
Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, Krautkramer MJ, Kung HF, Coleman RE, Doraiswamy PM, Fleisher AS, Sabbagh MN, Sadowsky CH, Reiman EM, Zehntner SP, Skovronsky DM, for the AV45-A07 Study Group (2011) Use of florbetapir-PET for imaging -amyloid pathology. JAMA 305, 275-283.
-
(2011)
JAMA
, vol.305
, pp. 275-283
-
-
Clark, C.M.1
Schneider, J.A.2
Bedell, B.J.3
Beach, T.G.4
Bilker, W.B.5
Mintun, M.A.6
Pontecorvo, M.J.7
Hefti, F.8
Carpenter, A.P.9
Flitter, M.L.10
Krautkramer, M.J.11
Kung, H.F.12
Coleman, R.E.13
Doraiswamy, P.M.14
Fleisher, A.S.15
Sabbagh, M.N.16
Sadowsky, C.H.17
Reiman, E.M.18
Zehntner, S.P.19
Skovronsky, D.M.20
more..
-
53
-
-
43849083580
-
Post-mortem correlates of in vivo PiBPET amyloid imaging in a typical case of Alzheimer's disease
-
Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST (2008) Post-mortem correlates of in vivo PiBPET amyloid imaging in a typical case of Alzheimer's disease. Brain 131, 1630-1645.
-
(2008)
Brain
, vol.131
, pp. 1630-1645
-
-
Ikonomovic, M.D.1
Klunk, W.E.2
Abrahamson, E.E.3
Mathis, C.A.4
Price, J.C.5
Tsopelas, N.D.6
Lopresti, B.J.7
Ziolko, S.8
Bi, W.9
Paljug, W.R.10
Debnath, M.L.11
Hope, C.E.12
Isanski, B.A.13
Hamilton, R.L.14
DeKosky, S.T.15
-
54
-
-
78650698306
-
Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease
-
Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A (2011) Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain 134, 301-317.
-
(2011)
Brain
, vol.134
, pp. 301-317
-
-
Kadir, A.1
Marutle, A.2
Gonzalez, D.3
Schöll, M.4
Almkvist, O.5
Mousavi, M.6
Mustafiz, T.7
Darreh-Shori, T.8
Nennesmo, I.9
Nordberg, A.10
-
55
-
-
84858336551
-
Ante mortem amyloid imaging and -amyloid pathology in a case with dementia with Lewy bodies
-
Kantarci K, Yang C, Schneider JA, Senjem ML, Reyes DA, Lowe VJ, Barnes LL, Aggarwal NT, Bennett DA, Smith GE, Petersen RC, Jack CR Jr., Boeve BF (2010) Ante mortem amyloid imaging and -amyloid pathology in a case with dementia with Lewy bodies. Neurobiol Aging 33, 878-885.
-
(2010)
Neurobiol Aging
, vol.33
, pp. 878-885
-
-
Kantarci, K.1
Yang, C.2
Schneider, J.A.3
Senjem, M.L.4
Reyes, D.A.5
Lowe, V.J.6
Barnes, L.L.7
Aggarwal, N.T.8
Bennett, D.A.9
Smith, G.E.10
Petersen, R.C.11
Jack Jr., C.R.12
Boeve, B.F.13
-
56
-
-
84867880031
-
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy
-
Gurol ME, Dierksen G, Betensky R, Gidicsin C, Halpin A, Becker A, Carmasin J, Ayres A, Schwab K, Viswanathan A, Salat D, Rosand J, Johnson KA, Greenberg SM (2012) Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology 79, 320-326.
-
(2012)
Neurology
, vol.79
, pp. 320-326
-
-
Gurol, M.E.1
Dierksen, G.2
Betensky, R.3
Gidicsin, C.4
Halpin, A.5
Becker, A.6
Carmasin, J.7
Ayres, A.8
Schwab, K.9
Viswanathan, A.10
Salat, D.11
Rosand, J.12
Johnson, K.A.13
Greenberg, S.M.14
-
57
-
-
34948819200
-
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
-
Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, Smith EE, Rosand J, Rentz DM, Klunk WE, Mathis CA, Price JC, Dekosky ST, Fischman AJ, Greenberg SM (2007) Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 62, 229-234.
-
(2007)
Ann Neurol
, vol.62
, pp. 229-234
-
-
Johnson, K.A.1
Gregas, M.2
Becker, J.A.3
Kinnecom, C.4
Salat, D.H.5
Moran, E.K.6
Smith, E.E.7
Rosand, J.8
Rentz, D.M.9
Klunk, W.E.10
Mathis, C.A.11
Price, J.C.12
Dekosky, S.T.13
Fischman, A.J.14
Greenberg, S.M.15
-
58
-
-
34848885454
-
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis
-
Lockhart A, Lamb JR, Osredkar T, Sue LI, Joyce JN, Ye L, Libri V, Leppert D, Beach TG (2007) PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain 130, 2607-2615.
-
(2007)
Brain
, vol.130
, pp. 2607-2615
-
-
Lockhart, A.1
Lamb, J.R.2
Osredkar, T.3
Sue, L.I.4
Joyce, J.N.5
Ye, L.6
Libri, V.7
Leppert, D.8
Beach, T.G.9
-
59
-
-
84055213660
-
Resorufin analogs preferentially bind cerebrovascular amyloid: Potential use as imaging ligands for cerebral amyloid angiopathy
-
Han BH, Zhou M, Vellimana AK, Milner E, Kim DH, Greenberg JK, Chu W, Mach RH, Zipfel GJ (2011) Resorufin analogs preferentially bind cerebrovascular amyloid: Potential use as imaging ligands for cerebral amyloid angiopathy. Mol Neurodegener 6, 86.
-
(2011)
Mol Neurodegener
, vol.6
, pp. 86
-
-
Han, B.H.1
Zhou, M.2
Vellimana, A.K.3
Milner, E.4
Kim, D.H.5
Greenberg, J.K.6
Chu, W.7
Mach, R.H.8
Zipfel, G.J.9
-
60
-
-
79951520786
-
In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults
-
Sojkova J, Driscoll I, Iacono D, Zhou Y, Codispoti KE, Kraut MA, Ferrucci L, Pletnikova O, Mathis CA, Klunk WE, O'Brien RJ, Wong DF, Troncoso JC, Resnick SM (2011) In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults. Arch Neurol 68, 232-240.
-
(2011)
Arch Neurol
, vol.68
, pp. 232-240
-
-
Sojkova, J.1
Driscoll, I.2
Iacono, D.3
Zhou, Y.4
Codispoti, K.E.5
Kraut, M.A.6
Ferrucci, L.7
Pletnikova, O.8
Mathis, C.A.9
Klunk, W.E.10
O'Brien, R.J.11
Wong, D.F.12
Troncoso, J.C.13
Resnick, S.M.14
-
61
-
-
61449129068
-
11 C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients
-
SvedbergMM, Hall H, Hellström-Lindahl E, Estrada S, Guan Z, Nordberg A, L̊angström B (2009) [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochem Int 54, 347-357.
-
(2009)
Neurochem Int
, vol.54
, pp. 347-357
-
-
Svedberg, M.M.1
Hall, H.2
Hellström-Lindahl, E.3
Estrada, S.4
Guan, Z.5
Nordberg, A.6
L̊angström, B.7
-
62
-
-
84857843988
-
Early AD pathology in a [C-11] PiB-negative case: A PiB-amyloid imaging, biochemical, and immunohistochemical study
-
Ikonomovic MD, Abrahamson EE, Price JC, Hamilton RL, Mathis CA, Paljug WR, Debnath ML, Cohen AD, Mizukami K, DeKosky ST, Lopez OL, Klunk WE (2012) Early AD pathology in a [C-11]PiB-negative case: A PiB-amyloid imaging, biochemical, and immunohistochemical study. Neuropathol 123, 433-447.
-
(2012)
Neuropathol
, vol.123
, pp. 433-447
-
-
Ikonomovic, M.D.1
Abrahamson, E.E.2
Price, J.C.3
Hamilton, R.L.4
Mathis, C.A.5
Paljug, W.R.6
Debnath, M.L.7
Cohen, A.D.8
Mizukami, K.9
DeKosky, S.T.10
Lopez, O.L.11
Klunk, W.E.12
-
63
-
-
84866062205
-
The exception makes the rule Not all A- plaques are created equal
-
Ringman JM, Teplow DB, Villemagne VI (2012) The exception makes the rule. Not all A- plaques are created equal. Neurology 79, 206-207.
-
(2012)
Neurology
, vol.79
, pp. 206-207
-
-
Ringman, J.M.1
Teplow, D.B.2
Villemagne, V.I.3
-
64
-
-
27944471285
-
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain
-
Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, Debnath ML, Holt DP, Huang GF, Shao L, DeKosky ST, Price JC, Mathis CA (2005) Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 25, 10598-10606.
-
(2005)
J Neurosci
, vol.25
, pp. 10598-10606
-
-
Klunk, W.E.1
Lopresti, B.J.2
Ikonomovic, M.D.3
Lefterov, I.M.4
Koldamova, R.P.5
Abrahamson, E.E.6
Debnath, M.L.7
Holt, D.P.8
Huang, G.F.9
Shao, L.10
DeKosky, S.T.11
Price, J.C.12
Mathis, C.A.13
-
65
-
-
78649846020
-
PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease
-
Rosen RF, Walker LC, Levine H 3rd (2011) PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging 32, 223-234.
-
(2011)
Neurobiol Aging
, vol.32
, pp. 223-234
-
-
Rosen, R.F.1
Walker, L.C.2
Levine III, H.3
-
66
-
-
54049120245
-
Assessment of betaamyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled pittsburgh compound b
-
Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, N̊agren K, Tapiola T, Pirttilä T, Rinne J, Jääskeläinen JE, Soininen H, Rinne JO (2008) Assessment of betaamyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol 65, 1304-1309.
-
(2008)
Arch Neurol
, vol.65
, pp. 1304-1309
-
-
Leinonen, V.1
Alafuzoff, I.2
Aalto, S.3
Suotunen, T.4
Savolainen, S.5
N̊agren, K.6
Tapiola, T.7
Pirttilä, T.8
Rinne, J.9
Jääskeläinen, J.E.10
Soininen, H.11
Rinne, J.O.12
-
67
-
-
73549123897
-
Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: A case report
-
Cairns NJ, Ikonomovic MD, Benzinger T, Storandt M, Fagan AM, Shah AR, Reinwald LT, Carter D, Felton A, Holtzman DM, Mintun MA, Klunk WE, Morris JC (2009) Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: A case report. Arch Neurol 66, 1557-1562.
-
(2009)
Arch Neurol
, vol.66
, pp. 1557-1562
-
-
Cairns, N.J.1
Ikonomovic, M.D.2
Benzinger, T.3
Storandt, M.4
Fagan, A.M.5
Shah, A.R.6
Reinwald, L.T.7
Carter, D.8
Felton, A.9
Holtzman, D.M.10
Mintun, M.A.11
Klunk, W.E.12
Morris, J.C.13
-
68
-
-
74049124939
-
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
-
Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ (2010) In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology 74, 77-84.
-
(2010)
Neurology
, vol.74
, pp. 77-84
-
-
Burack, M.A.1
Hartlein, J.2
Flores, H.P.3
Taylor-Reinwald, L.4
Perlmutter, J.S.5
Cairns, N.J.6
-
69
-
-
69449086022
-
11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease
-
Villemagne VL, McLean CA, Reardon K, Boyd A, Lewis V, Klug G, Jones G, Baxendale D, Masters CL, Rowe CC, Collins SJ (2009) 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 80, 998-1001.
-
(2009)
J Neurol Neurosurg Psychiatry
, vol.80
, pp. 998-1001
-
-
Villemagne, V.L.1
McLean, C.A.2
Reardon, K.3
Boyd, A.4
Lewis, V.5
Klug, G.6
Jones, G.7
Baxendale, D.8
Masters, C.L.9
Rowe, C.C.10
Collins, S.J.11
-
70
-
-
79959191029
-
Multimodal imaging of Alzheimer pathophysiology in the brain's default mode network
-
Shin J, Kepe K, Small GW, Phelps ME, Barrio JR (2011) Multimodal imaging of Alzheimer pathophysiology in the brain's default mode network. Int J Alzheimers Dis 2011, 687945.
-
(2011)
Int J Alzheimers Dis
, vol.2011
, pp. 687945
-
-
Shin, J.1
Kepe, K.2
Small, G.W.3
Phelps, M.E.4
Barrio, J.R.5
-
71
-
-
0025717816
-
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
-
Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1, 103-116.
-
(1991)
Cereb Cortex
, vol.1
, pp. 103-116
-
-
Arnold, S.E.1
Hyman, B.T.2
Flory, J.3
Damasio, A.R.4
Van Hoesen, G.W.5
-
72
-
-
0032989712
-
Tangles and plaques in nondemented aging and preclinical Alzheimer's disease
-
Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45, 358-368.
-
(1999)
Ann Neurol
, vol.45
, pp. 358-368
-
-
Price, J.L.1
Morris, J.C.2
-
73
-
-
75149181071
-
Neocortical variation of Abeta load in fully expressed, pure Alzheimer's disease
-
Cupidi C, Capobianco R, Goffredo D, Marcon G, Ghetti B, Bugiani O, Tagliavini F, Giaccone G (2010) Neocortical variation of Abeta load in fully expressed, pure Alzheimer's disease. J Alzheimers Dis 19, 57-68.
-
(2010)
J Alzheimers Dis
, vol.19
, pp. 57-68
-
-
Cupidi, C.1
Capobianco, R.2
Goffredo, D.3
Marcon, G.4
Ghetti, B.5
Bugiani, O.6
Tagliavini, F.7
Giaccone, G.8
-
74
-
-
33747048954
-
11C] PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
-
Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC (2006) [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67, 446-452.
-
(2006)
Neurology
, vol.67
, pp. 446-452
-
-
Mintun, M.A.1
Larossa, G.N.2
Sheline, Y.I.3
Dence, C.S.4
Lee, S.Y.5
Mach, R.H.6
Klunk, W.E.7
Mathis, C.A.8
DeKosky, S.T.9
Morris, J.C.10
-
75
-
-
33748692453
-
Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease
-
Ziolko SK, Weissfeld LA, Klunk WE, Mathis CA, Hoge JA, Lopresti BJ, DeKosky ST, Price JC (2006) Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. Neuroimage 33, 94-102.
-
(2006)
Neuroimage
, vol.33
, pp. 94-102
-
-
Ziolko, S.K.1
Weissfeld, L.A.2
Klunk, W.E.3
Mathis, C.A.4
Hoge, J.A.5
Lopresti, B.J.6
DeKosky, S.T.7
Price, J.C.8
-
76
-
-
34248231779
-
PET amyloid ligand [11C] PIB uptake is increased in mild cognitive impairment
-
Kemppainen NM, Aalto S, Wilson IA, N̊agren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO (2007) PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology 68, 1603-1606.
-
(2007)
Neurology
, vol.68
, pp. 1603-1606
-
-
Kemppainen, N.M.1
Aalto, S.2
Wilson, I.A.3
N̊agren, K.4
Helin, S.5
Brück, A.6
Oikonen, V.7
Kailajärvi, M.8
Scheinin, M.9
Viitanen, M.10
Parkkola, R.11
Rinne, J.O.12
-
77
-
-
84860220102
-
Subacute ischemic stroke is associated with focal 11C PiB positron emission tomography retention but not with global neocortical A- deposition
-
Ly JV, Rowe CC, Villemagne VL, Zavala JA,Ma H, Sahathevan R, O'Keefe G, Gong SJ, Gunawan R, Churilov L, Saunder T, Ackerman U, Tochon-Danguy H, DonnanGA(2012) Subacute ischemic stroke is associated with focal 11C PiB positron emission tomography retention but not with global neocortical A- deposition. Stroke 43, 1341-1346.
-
(2012)
Stroke
, vol.43
, pp. 1341-1346
-
-
Ly, J.V.1
Rowe, C.C.2
Villemagne, V.L.3
Zavala, J.A.4
Ma, H.5
Sahathevan, R.6
O'Keefe, G.7
Gong, S.J.8
Gunawan, R.9
Churilov, L.10
Saunder, T.11
Ackerman, U.12
Tochon-Danguy, H.13
Donnan, G.A.14
-
79
-
-
77950913030
-
Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates
-
Cole GB, Keum G, Liu J, Small GW, Satyamurthy N, Kepe V, Barrio JR (2010) Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates. Proc Natl Acad Sci U S A 107, 6222-6227.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 6222-6227
-
-
Cole, G.B.1
Keum, G.2
Liu, J.3
Small, G.W.4
Satyamurthy, N.5
Kepe, V.6
Barrio, J.R.7
-
80
-
-
0036924550
-
Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues
-
Miki Y, Nakata T, Suzuki T, Darnel AD, Moriya T, Kaneko C, Hidaka K, Shiotsu Y, Kusaka H, Sasano H (2002) Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues. J Clin Endocrinol Metab 87, 5760-5768.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 5760-5768
-
-
Miki, Y.1
Nakata, T.2
Suzuki, T.3
Darnel, A.D.4
Moriya, T.5
Kaneko, C.6
Hidaka, K.7
Shiotsu, Y.8
Kusaka, H.9
Sasano, H.10
-
81
-
-
27544487563
-
Species-dependent metabolism of the amyloid imaging agent [C-11]PIB
-
Mathis CA, Holt DP,Wang Y, Huang GF, Debnath ML, Shao L, Klunk WE (2004) Species-dependent metabolism of the amyloid imaging agent [C-11]PIB. J Nucl Med 45(Supp l), 114P.
-
(2004)
J Nucl Med
, vol.45
, Issue.SUPPL. 1
, pp. 114
-
-
Mathis, C.A.1
Holt, D.P.2
Wang, Y.3
Huang, G.F.4
Debnath, M.L.5
Shao, L.6
Klunk, W.E.7
-
82
-
-
84858607421
-
Clinical validation of 18F-AZD4694, an amyloid-specific PET radioligand
-
Cseényi Z, Jönhagen ME, Forsberg A, Halldin C, Julin P, Schou M, Johnström P, Varnäs K, Svensson S, Farde L (2012) Clinical validation of 18F-AZD4694, an amyloid-specific PET radioligand. J Nucl Med 53, 415-424.
-
(2012)
J Nucl Med
, vol.53
, pp. 415-424
-
-
Cseényi, Z.1
Jönhagen, M.E.2
Forsberg, A.3
Halldin, C.4
Julin, P.5
Schou, M.6
Johnström, P.7
Varnäs, K.8
Svensson, S.9
Farde, L.10
-
83
-
-
0037444535
-
The binding of 2-(4-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component
-
Klunk WE,Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, Hamilton RL, Ikonomovic MD, DeKosky ST, Mathis CA (2003) The binding of 2-(4- methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 23, 2086-2092.
-
(2003)
J Neurosci
, vol.23
, pp. 2086-2092
-
-
Klunk, W.E.1
Wang, Y.2
Huang, G.F.3
Debnath, M.L.4
Holt, D.P.5
Shao, L.6
Hamilton, R.L.7
Ikonomovic, M.D.8
DeKosky, S.T.9
Mathis, C.A.10
-
84
-
-
37349126921
-
Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3-Me-BTA-1 as potential radiotracers for in vivo imaging of beta-amyloid plaques
-
Neumaier B, Deisenhofer S, Fürst D, von Arnim CA, Thees S, BuckAK,Glatting G, Landwehrmeyer GB, Krause BJ,Müller HD, Sommer C, Reske SN, Mottaghy FM (2007) Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3-Me-BTA-1 as potential radiotracers for in vivo imaging of beta-amyloid plaques. Nuklearmedizin 46, 271-280.
-
(2007)
Nuklearmedizin
, vol.46
, pp. 271-280
-
-
Neumaier, B.1
Deisenhofer, S.2
Fürst, D.3
Von Arnim, C.A.4
Thees, S.5
Buck, A.K.6
Glatting, G.7
Landwehrmeyer, G.B.8
Krause, B.J.9
Müller, H.D.10
Sommer, C.11
Reske, S.N.12
Mottaghy, F.M.13
-
85
-
-
84872379077
-
Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers
-
Jack CR Jr., Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P,Wiste HJ,Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol 12, 207-216.
-
(2013)
Lancet Neurol
, vol.12
, pp. 207-216
-
-
Jack Jr., C.R.1
Knopman, D.S.2
Jagust, W.J.3
Petersen, R.C.4
Weiner, M.W.5
Aisen, P.S.6
Shaw, L.M.7
Vemuri, P.8
Wiste, H.J.9
Weigand, S.D.10
Lesnick, T.G.11
Pankratz, V.S.12
Donohue, M.C.13
Trojanowski, J.Q.14
|